Commit To Purchase Acorda Therapeutics At $13, Earn 14.2% Annualized Using Options
April 25, 2017 at 11:45 AM EDT
Investors considering a purchase of Acorda Therapeutics Inc (ACOR) shares, but tentative about paying the going market price of $16.35/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $13 strike, which has a bid at the time of this writing of 90 cents..